A new definition and treatment options of allergic alveolitis

Ugeskr Laeger. 2024 Apr 1;186(14):V11230705. doi: 10.61409/V11230705.
[Article in Danish]

Abstract

In this review, we discuss a new definition and treatment options of allergic alveolitis (AA). AA is an immune-mediated interstitial lung disease triggered by inhaled antigens, it is defined as non-fibrotic (inflammatory) and/or fibrotic, and diagnosis relies on a multidisciplinary approach using clinical, radiological and sometimes histological assessments. Treatment involves early antigen elimination and may include corticosteroids or other immunosuppressants. Prognosis varies from reversible inflammation to irreversible fibrosis. Early detection is crucial for better outcomes.

Publication types

  • Review
  • English Abstract

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Alveolitis, Extrinsic Allergic*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lung / pathology
  • Lung Diseases, Interstitial* / drug therapy
  • Lung Diseases, Interstitial* / therapy
  • Prognosis

Substances

  • Adrenal Cortex Hormones
  • Immunosuppressive Agents